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Dear Editor,
Adamantiades-Behçet’s disease (ABD) is an inflam-
matory disease classified as vasculitis, which was origi-
nally diagnosed in patients with aphthous stomatitis, 
genital ulcerations, and ocular manifestations. Howev-
er, any organ or system may be involved, particularly 
the central and peripheral nervous systems, joints, as 
well as the gastrointestinal tract. The etiology of ABD is 
still not fully understood, but some evidence indicates 
that an autoimmune process could be triggered by an 
infectious or environmental agent specific for the geo-
graphic region (1). Although BD can occur worldwide, 
it is most prevalent in the region along the ancient 
commercial route called the “Silk Road”. In Italy, stud-
ies on the precise prevalence of ABD are lacking (2). As 
there are no specific diagnostic laboratory tests or his-
topathologic findings which confirm the preliminary 
diagnosis, the final diagnosis should be based on clini-
cal criteria (3). Skin and mucosae are the target organs 
of this disease, and therefore their involvement has 
been considered in the numerous diagnostic criteria 
developed over the years (4). The first most important 
and popular criteria were created in 1990 by the In-
ternational Study Group (ISG) (5). Because of their low 
sensitivity, the new International Criteria for Behçet’s 
Disease (ICBD) were established, and were presented 
at the International Conference of Behçet’s Disease in 
Lisbon in 2006 (6,7). In 2014, the International Team for 
the Revision of the International Criteria for BD submit-
ted new criteria assigning 2 points to ocular lesions, 
oral aphthosis, and genital aphthosis, and 1 point to 
skin lesions, central nervous system involvement, and 
vascular manifestations. The pathergy test, when used, 
was assigned 1 point. A patient scoring ≥4 points is 
classified as having BD (8). We performed a single cen-
ter, case-control study on a cohort of patients of Friuli 
Venezia Giulia, enrolled from January 2010 to Septem-
ber 2015 in the Dermatology Unit of the University of 
Trieste. The aim was to analyze the clinical features and 
compare the sensitivity, specificity, and accuracy of the 
three diagnostic criteria for ABD presented above in 
patients born in this particular region which is located 
at the very start of the “Silk Route”. 
We enrolled 153 consecutive patients (74 cases 
and 79 controls) in the study. The characteristics and 
clinical features of patients and controls are summa-
rized in Table 1. The most common diagnoses in the 
control group were recurrent oral aphtosis, lichen 
planus, mucous-membrane pemphigoid, and lupus 
erythematosus. The inclusion criterion was the pres-
ence of at least one principal clinical feature of ABD 
(oral aphtosis, genital aphtosis, skin lesions, ocular in-
volvement) properly recorded in clinical records. Pa-
tient recruitment was done in a consecutive manner. 
Exclusion criteria were incomplete clinical records 
and absence of follow-up data.
The diagnosis of ABD was established by expert 
dermatologists, without the use of any particular 
diagnostic criterion. For ABD, diagnosis agreement 
among dermatologists was required. The study was 
conducted according to the Declaration of Helsinki 
protocols. 
Possible associations between categorical vari-
ables were detected by the use of Fisher’s exact test 
or Pearson χ2 test, depending on the sample size. Lo-
gistic regression was performed in order to identify 
which symptoms are of higher impact in the diagno-
sis of ABD. A comparison in terms of sensitivity, speci-
ficity, and accuracy among the three diagnostic crite-
ria (ISG 1990, ITR 2006, and ITR 2014) was performed. 
The receiver operator characteristic (ROC) curve was 
obtained for each diagnostic criterion.
Data were produced with a 95% confidence inter-
val; P values <0.05 were considered statistically sig-
nificant. Statistical analysis was done using Stata SE12 
software (Stata Corporation, Tx, USA). 
According to our data, patients with ABD had a 
significantly lower age at diagnosis compared with 
controls (P=0.0001); this was confirmed for both men 
(P=0.0006) and women (P=0.004). The presence of 
oral aphtosis was not necessarily pathognomonic of 
ABD (P=0.005) as it was found in 97.3% of patients 
with ABD and in 83.5% of controls. Genital aphtosis 
was directly associated with ABD diagnosis (P<0.001), 
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Table 2. Results of logistic regression
Clinical Features Odds ratio P value
Younger age 0.8950334 0.000
Oral aphtosis 145.3229 0.004
Genital aphtosis 12947.7 0.000
Skin involvement 104.5625 0.002
Neurological inolvement 819.263 0.001
Vacular involvement 240.2573 0.000
Table 1. Comparison between the clinical characteristics of patients and controls
Behçet Disease (n=74, M=21, F=53)    Controls (n=79, M=13, F=66)                P value
Age 45.79 ± 13.25 56.09 ± 17.78 0.0001
Age if Male 42.78 ± 11.71 62.43 ± 20.55 0.0006
Age if Female 46.98 ±13.73 54.84 ± 17.08 0.0038
Oral aphtosis 72 (97.30%) 66 (83.54%) 0.005
Genital aphtosis 59 (79.73%) 7 (8.86%) 0.000
Skin manifestations 46 (62.16%) 22 (27.85%) 0.000
Pseudofolliculitis 33 (44.59%) 13 (16.46%) 0.000
Erythema nodosum 18 (24.32%) 10 (12.66%) 0.093
Cutaneous aphtosis 1 (1.35%) 0 (0.00%) 0.484
Ocular lesions 16 (21.62%) 4 (5.06%) 0.003
Anterior uveitis 14 (18.92%) 2 (2.53%) 0.001
Posterior uveitis 4 (5.41%) 2 (2.53%) 0.0431
Retinal vasculitis 1 (1.35%) 1 (1.27%) 0.963
Joint manifestations 34 (45.95%) 32 (40.51%) 0.518
Arthralgia 27 (36.49%) 25 (31.65%) 0.609
Arthritis 7 (9.46%) 7 (8.86%) 0.898
Spondylitis 1 (1.35%) 1 (1.27%) 0.963
Neurological manifestations 11 (14.86%) 4 (5.06%) 0.056
Peripheral 5 (6.76%) 4 (5.06%) 0.740
Central 6 (8.11%) 0 (0%) 0.011
Vascular manifestations 10 (13.51%) 3 (3.80%) 0.042
Arterial thrombosis 1 (1.35%) 0 (0%) 0.484
Venous thrombosis 3 (4.05%) 1 (1.27%) 0.354
Phlebitis 7 (9.46%) 3 (3.80%) 0.1999
Gastrointestinal manifestations 11 (14.86%) 0 (0.00%) 0.000
Epididymitis 2 (2.70%) 0 (0.00%) 0.232
Pathergy test positive 17 (36.17%) 1 (4.76%) 0.007
HLA B51 test positive 26 (70.27%) 9 (34.62%) 0.009
as it was present in 79.7% of patients with ABD, but in 
only 8.9% of controls. Furthermore, even skin mani-
festations and ocular lesions were observed at differ-
ent rates in patients with ABD and controls (P<0.001 
and P=0.003, respectively). The presence of pseu-
dofolliculitis was significantly more frequent in pa-
tients than in controls (P<0.001), whereas erythema 
nodosum and skin aphtosis did not differ consider-
ably between ABD and controls. Joint manifestations 
were as common in patients with ABD as in controls 
(P=0.6): arthralgia and arthritis alone do not indicate 
a diagnosis of ABD. Neurological symptoms as well as 
vascular involvement, if present, can be suggestive of 
ABD, but their absence does not exclude an ABD di-
agnosis (P=0.06 and P=0.04). Positive pathergy tests 
and positive HLA B51 tests were significantly more 
frequent in patients than in controls (P=0.007 and 
Figure 1. Results of receiver operator characteristic (ROC) 
areas.
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P=0.009, respectively), although if negative they did 
not exclude a diagnosis of ABD.
Logistic regression showed that genital aph-
tosis (odds ratio (OR)=12948, P<0.001), neurologi-
cal manifestations (OR=819.263, P=0.001), vascular 
manifestations (OR=240.2573, P=0.001), cutaneous 
manifestations (OR=104.5625, P=0.002), oral aphtosis 
(OR=145.3229, P=0.004), and younger age at diag-
nosis (OR=0.8950334, P=0.000) were associated with 
ABD diagnosis (Table 2). There was no single pathog-
nomonic symptom of ABD.
We found that the ITR criteria –both from 2006 
and 2014 – had a higher sensitivity (98.7% and 100%, 
respectively), specificity (94.9% and 97.9%, respec-
tively), and accuracy (96.7% and 98.7%, respectively) 
compared with the ISG 1990 criterion, which scored 
66% sensitivity, 100% specificity, and 83.7% accuracy. 
Area Under Roc Curve (AUC) was significantly differ-
ent between ISG 1990 and ITR 2006 and between ISG 
1990 and ITR 2014 (Figure 1). Even though no statis-
tically significant difference was found between the 
ITR 2014 and ITR 2006 criteria, the former had a better 
performance according to our records.  
The clinical features reported in our retrospective 
case-control study are comparable to data found in 
the literature from European and international re-
ports.
A recent study (8) found a similar organ involve-
ment percentage to our study, although we found a 
higher prevalence of HLA B51 positive patients and a 
lower percentage of ocular manifestations in our re-
cords. The results of the logistic regression performed 
based on our records indicate genital aphtosis, oral 
aphtosis, ocular involvement, neurological signs, and 
vascular features are more strongly linked to the di-
agnosis of ABD. According to our data, the presence 
of oral aphtosis is not paramount for the diagnosis of 
ABD, which fits well with the intent of the ITR 2006 
and 2014 diagnostic criteria. The new ITR 2014 criteria 
added neurological signs to the diagnostic symptoms 
of ABD, emphasizing the importance of a multidisci-
plinary approach to patients suspected to have ABD.
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